文献速递淋巴瘤

α-酮戊二酸促进氨基酸耗竭并抑制B细胞淋巴瘤生长与发展

α-Ketoglutarate promotes amino acid depletion and suppresses B-cell lymphoma growth and development.
PubMed 文献 · Blood · 2025-01-01

研究探讨外源性补充α-酮戊二酸(αKG)对B细胞淋巴瘤氨基酸代谢及肿瘤生长的影响。αKG介导天冬氨酸及支链氨基酸(亮氨酸、缬氨酸、异亮氨酸)快速持续耗竭,抑制mTORC1活性,在体外和体内抑制淋巴瘤生长;长期膳食补充αKG可显著阻碍Eμ-Myc小鼠淋巴瘤发生。

要点

  • αKG补充介导B细胞淋巴瘤中天冬氨酸及支链氨基酸快速持续耗竭。
  • 亮氨酸水平下降影响mTORC1亚细胞定位并抑制其活性,与淋巴瘤生长抑制相关。
  • 长期膳食补充αKG显著阻碍Eμ-Myc小鼠淋巴瘤发生,伴氨基酸扰动和能量生成受损。

核心结论

  • αKG补充介导氨基酸耗竭并抑制B细胞淋巴瘤生长与发展,作者认为αKG补充兼具抗癌特性。

研究设计与样本

  • 以B细胞淋巴瘤为模型系统,开展体外和体内研究,并使用Eμ-Myc小鼠进行长期膳食补充实验。

主要发现

  • αKG介导天冬氨酸以及亮氨酸、缬氨酸和异亮氨酸的快速持续耗竭。
  • 亮氨酸水平下降影响mTORC1亚细胞定位、抑制其活性,并与体外和体内B细胞淋巴瘤生长抑制相关。
  • 增加淋巴瘤细胞天冬氨酸或亮氨酸摄入、基因强制mTORC1溶酶体定位或通过支链氨基酸转氨酶2缺失阻断亮氨酸分解代谢,均削弱αKG的抗淋巴瘤效应。
  • 长期膳食补充αKG显著阻碍Eμ-Myc小鼠淋巴瘤发生,伴氨基酸扰动和能量生成受损。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Targeting metabolic dependencies and "starving" malignant cells have long been considered potential strategies to treat cancer. However, with rare exceptions, the implementation of these maneuvers has been fraught with limited activity and lack of specificity. Multiple cytoplasmic and mitochondrial transaminases catalyze reactions that lead to amino acid catabolism. These enzymes use α-ketoglutarate (αKG) as a nitrogen acceptor, and accumulation of the competitive inhibitor metabolite D-2-hydroxyglutarate perturbs their function. We postulated that exogenous αKG supplementation would influence the directionality of these reactions and deplete amino acids in cancer cells. Using B-cell lymphoma as a model system, we found that αKG mediates a rapid and sustained amino acid depletion, principally of aspartate and branched-chain leucine, valine, and isoleucine. The decrease in leucine levels influenced mammalian target of rapamycin complex 1 (mTORC1) subcellular movement, suppressed its activity, and associated with inhibition of B-cell lymphoma growth in vitro and in vivo. Increasing import of aspartate or leucine levels in the lymphoma cells, genetically forcing mTORC1 lysosomal localization or blocking leucine catabolism through branched-chain amino acid transaminase 2 deletion, all blunted the antilymphoma effects of αKG. In addition, long-term dietary supplementation of αKG, a toxicity-free strategy, significantly hindered lymphoma development in Eμ-Myc mice, in association with amino acid perturbation and impaired energy generation. We posit that αKG supplementation, which has been shown to improve health and life span in mice, also encodes marked anticancer properties.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Jaafar C, Ethiraj P, Qiu Z, et al. α-Ketoglutarate promotes amino acid depletion and suppresses B-cell lymphoma growth and development. Blood. 2025. PMID: 40700634. doi:10.1182/blood.2024028069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。